Antinuclear antibody–positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis

Abstract

Our findings substantiate the hypothesis that ANA-positive patients classified into different JIA categories by current ILAR criteria constitute a homogeneous patient population.